These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 7858694)

  • 41. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700- to 1350-gram infants with respiratory distress syndrome. The American Exosurf Neonatal Study Group I.
    Long W; Thompson T; Sundell H; Schumacher R; Volberg F; Guthrie R
    J Pediatr; 1991 Apr; 118(4 Pt 1):595-605. PubMed ID: 2007938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective randomized comparison of conventional mechanical ventilation and very early high frequency oscillatory ventilation in extremely premature newborns with respiratory distress syndrome.
    Plavka R; Kopecký P; Sebron V; Svihovec P; Zlatohlávková B; Janus V
    Intensive Care Med; 1999 Jan; 25(1):68-75. PubMed ID: 10051081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Sanghvi KP; Merchant RH
    Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
    [No Abstract]   [Full Text] [Related]  

  • 44. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk for adverse outcomes.
    Wiswell TE; Graziani LJ; Kornhauser MS; Cullen J; Merton DA; McKee L; Spitzer AR
    Pediatrics; 1996 Dec; 98(6 Pt 1):1035-43. PubMed ID: 8951251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
    Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
    Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter randomized trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure.
    Ogawa Y; Miyasaka K; Kawano T; Imura S; Inukai K; Okuyama K; Oguchi K; Togari H; Nishida H; Mishina J
    Early Hum Dev; 1993 Feb; 32(1):1-10. PubMed ID: 8462430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative randomized study: administration of natural and synthetic surfactant to premature newborns with respiratory distress syndrome.
    Giannakopoulou C; Hatzidaki E; Korakaki E; Christodoulaki M; Margari KM; Mamoulakis D
    Pediatr Int; 2002 Apr; 44(2):117-21. PubMed ID: 11896865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved oxygenation during synchronized intermittent mandatory ventilation in neonates with respiratory distress syndrome: a randomized, crossover study.
    Cleary JP; Bernstein G; Mannino FL; Heldt GP
    J Pediatr; 1995 Mar; 126(3):407-11. PubMed ID: 7869203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation.
    Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M
    Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Ardell S; Pfister RH; Soll R
    Cochrane Database Syst Rev; 2015 May; (5):CD000144. PubMed ID: 26009996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants.
    Yen TA; Wang CC; Hsieh WS; Chou HC; Chen CY; Tsao PN
    Pediatr Neonatol; 2013 Oct; 54(5):330-4. PubMed ID: 23711674
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surfactant and respiratory distress syndrome.
    Milner AD
    Turk J Pediatr; 1996; 38(1):37-43. PubMed ID: 8819619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome.
    Murdoch E; Kempley ST
    Eur J Pediatr; 2000 Oct; 159(10):767-9. PubMed ID: 11039133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuromotor outcome at 2 years of very preterm infants who were treated with high-frequency oscillatory ventilation or conventional ventilation for neonatal respiratory distress syndrome.
    Truffert P; Paris-Llado J; Escande B; Magny JF; Cambonie G; Saliba E; Thiriez G; Zupan-Simunek V; Blanc T; Rozé JC; Bréart G; Moriette G
    Pediatrics; 2007 Apr; 119(4):e860-5. PubMed ID: 17339385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant.
    Corbet AJ; Long WA; Murphy DJ; Garcia-Prats JA; Lombardy LR; Wold DE
    J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: effects on mortality rate. American Exosurf Neonatal Study Groups I and IIa.
    Corbet A; Gerdes J; Long W; Avila E; Puri A; Rosenberg A; Edwards K; Cook L
    J Pediatr; 1995 Jun; 126(6):969-78. PubMed ID: 7776110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current surfactant use in premature infants.
    Suresh GK; Soll RF
    Clin Perinatol; 2001 Sep; 28(3):671-94. PubMed ID: 11570160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.